CGEN Compugen Ltd.

NASDAQ
$2.14

Compugen Ltd. (CGEN) is confirmed to report earnings on November 9, 2026, before the market open. The consensus earnings estimate is a loss of $0.05 per share.

Compugen Beat Consensus Estimates
Monday, November 9, 2026 · 7:00 AM ET
Earnings Date
4th Quarter, Dec 2026
Nov 9
Monday · 7:00 AM ET
Earnings Whisper
-
vs ($0.05)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $2.36

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Compugen Ltd.

Compugen Ltd is a drug discovery and development company focused on therapeutic proteins and monoclonal antibodies to address important unmet needs in the fields of immunology and oncology.

Sector

Healthcare

Industry

Biotechnology

Charts powered in part by Lightweight Charts™ by TradingView.